Global Mannitol Market Size Study, By Application (Food Additive, Pharmaceuticals, Industrial, Surfactants, Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), and Regional Forecasts 2022-2032

The Global Mannitol Market was valued at USD 429.62 million in 2023 and is anticipated to grow with a CAGR of 5.0% over the forecast period 2024-2032, reaching approximately USD 666.48 Million by 2032. The market is experiencing significant momentum, driven by rising health-conscious consumer preferences and increasing applications across various industries, including pharmaceuticals, food and beverage, and industrial sectors. As an essential sugar alcohol, mannitol's unique properties, such as its low glycemic index and functional excipient capabilities, make it highly desirable across multiple segments. The increasing prevalence of diabetes and obesity, coupled with a growing demand for low-calorie and sugar-free food products, further accelerates market expansion.

Mannitol plays a crucial role in pharmaceutical formulations, serving as an excipient, osmotic diuretic, and bulking agent. Its extensive use in tablet coatings, injectable drugs, and treatments for kidney disorders, cerebral edema, and cardiovascular conditions continues to drive its demand in the healthcare sector. Additionally, with increasing R&D investments, pharmaceutical companies are exploring novel applications of mannitol in drug formulations and medical treatments.

The food and beverage industry remains a dominant consumer of mannitol, accounting for a significant revenue share in 2023. Due to shifting consumer preferences towards functional foods and natural sweeteners, mannitol is widely used in sugar-free confectionery, chewing gum, baked goods, and dairy products. The rising demand for artificial sweeteners and clean-label ingredients is expected to enhance the adoption of mannitol in processed food applications. Additionally, its minimal impact on blood sugar levels has positioned it as a preferred sugar substitute for diabetic-friendly products.

Regionally, Asia Pacific emerged as the largest market in 2023, accounting for a dominant revenue share due to its expanding food processing, pharmaceutical, and personal care industries. China led the regional market, driven by high demand for sugar alternatives, industrial applications, and pharmaceutical excipients. Meanwhile, North America and Europe are experiencing steady market growth due to the rising adoption of sugar-free products, regulatory approvals, and strong pharmaceutical demand.

Major Market Players Included in This Report Are:

• Roquette Freres
• Cargill, Incorporated
• Ingredion
• SPI Pharma
• Merck KGaA
• Singsino Group Ltd.
• Shijiazhuang Huaxu Pharmaceutical Co., Ltd.
• Rongde Seaweed Co., Ltd.
• Qingdao Mingyue Seaweed Group Co.
• Moga International Ltd.
• Tate & Lyle
• Archer Daniels Midland Company
• Dupont
• Novozymes
• Futaste Pharmaceutical Co. Ltd.

The Detailed Segments and Sub-Segments of the Market Are Explained Below:

By Application

• Food Additive
• Pharmaceuticals
• Industrial
• Surfactants
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa

Years Considered for the Study Are As Follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level market insights.
• Competitive landscape featuring market leaders, growth strategies, and company profiles.
• Insights into key business strategies, investments, and expansion initiatives.
• Competitive structure and analysis of top players operating in the market.
• Demand-side and supply-side evaluation of the market.